Chronic Leukemia | Medscape

Chronic Leukemia

Chronic Leukemia News

Alert Duvelisib Approved for Certain Lymphomas The FDA approved the new drug for use in relapsed or refractory chronic lymphocytic leukemia, small lymphocytic lymphoma, and follicular lymphoma.
FDA Approvals, September 25, 2018
Alert FDA Approves Lumoxiti, an Immunotoxin for Hairy Cell Leukemia Moxetumomab pasudotox is a CD22-directed cytotoxin or immunotoxin and is a first-in-class type of treatment for patients with HCL
FDA Approvals, September 13, 2018

Low-Dose Radiation Exposure Early in Life Tied to Higher Leukemia Risk
Reuters Health Information, August 1, 2018
EHA 2018 Mutations in Half of Patients With CLL Who Relapse on Ibrutinib
Medscape Medical News, June 27, 2018
EHA 2018 Survival Longer With Obinutuzumab Compared to Rituximab in CLL
Medscape Medical News, June 20, 2018
IWMF 2018 New Drugs Poised to Expand Treatment Horizons in WM
Medscape Medical News, May 25, 2018

Chronic Leukemia Perspective

Time Out! A Close Look at Antibiotic Use in LTC Clinical cases illustrate the overuse of antibiotics to treat radiographic findings and lab reports, especially when prescribing over the phone.
Medscape Infectious Diseases, October 2, 2018
EHA 2018 Read clinically focused news coverage of key developments from EHA 2018
Medscape Oncology, June 15, 2018

A 71-Year-Old Man With Malaise: USMLE Question
Osmosis, May 25, 2018
A 70-Year-Old Man With Splenomegaly: USMLE Question
Osmosis, April 20, 2018
Maximizing Response in Acute Leukemia: Pearls From ASH 2017
Medscape Oncology, January 29, 2018
With So Many Options, Best CLL Treatment May Be a Clinical Trial
Medscape Oncology, January 18, 2018

Journals

Critically Elevated Potassium in Chronic Lymphocytic Leukemia
Laboratory Medicine, September 19, 2018
Hepatitis B Virus and Risk of Non-Hodgkin Lymphoma
Journal of Viral Hepatitis, September 11, 2018
Immunotherapies in Oncology and Their Side Effect Profiles
Journal of the American Board of Family Medicine, August 30, 2018
Antioxidant for Taxane-Induced Neuropathy
Journal of the National Cancer Institute, August 3, 2018
CD19 Antibody MOR208 in Relapsed or Refractory B-Cell NHL
Annals of Oncology, July 26, 2018

Medscape Drugs & Diseases: Chronic Leukemia

Medscape Education: Chronic Leukemia

All material on this website is protected by copyright, Copyright © 1994-2018 by WebMD LLC. This website also contains material copyrighted by 3rd parties.